Related Experiment Video
Updated: May 19, 2026

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
MOGAD-Associated Recurrent Optic Neuritis Unresponsive to Corticosteroids: Clinical, Visual Field, and OCT
Cansu Kostakoğlu Duman1, Büşra Gülhan2, Yelda Yıldız Taşçı2
1Department of Neurology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey.
Background:
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune demyelinating disorder. In adults, optic neuritis is the most common initial manifestation.
Case Presentation:
We report the case of a 23-year-old woman presenting with right eye vision loss and severe optic disc edema. The condition was unresponsive to intravenous corticosteroids. Plasmapheresis led to marked improvement. Two months later, a second episode occurred in the left eye, despite ongoing steroid therapy.
Investigations:
Initial brain and orbital MRI were normal. Optical coherence tomography (OCT) showed increased RNFL thickness in the acute phase and progressive thinning during follow-up. Anti-MOG antibodies were detected at a 1:100 titer in serum, confirming the diagnosis.
Treatment And Outcome:
The patient was treated with plasmapheresis, oral steroids, and azathioprine during the first attack. After the second relapse, rituximab was initiated. The patient achieved visual recovery and has remained relapse-free for two years.
Conclusion:
Corticosteroid-unresponsive recurrent optic neuritis should prompt evaluation for MOGAD, especially in the presence of bilateral involvement and optic disc edema. OCT is valuable for monitoring disease activity and structural damage.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Diabetic Retinopathy
